Neuron
Volume 106, Issue 3, 6 May 2020, Pages 421-437.e11
Journal home page for Neuron

Article
Tau Reduction Prevents Key Features of Autism in Mouse Models

https://doi.org/10.1016/j.neuron.2020.01.038Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Tau reduction prevents autism-like behaviors in Scn1aRX/+ and Cntnap2−/− mice

  • Tau reduction also prevents PI3K overactivation and megalencephaly in these models

  • Tau interacts with PTEN via its proline-rich domain and suppresses PTEN activity

  • PTEN is a critical mediator of the beneficial effects of tau reduction

Summary

Autism is characterized by repetitive behaviors, impaired social interactions, and communication deficits. It is a prevalent neurodevelopmental disorder, and available treatments offer little benefit. Here, we show that genetically reducing the protein tau prevents behavioral signs of autism in two mouse models simulating distinct causes of this condition. Similar to a proportion of people with autism, both models have epilepsy, abnormally enlarged brains, and overactivation of the phosphatidylinositol 3-kinase (PI3K)/Akt (protein kinase B)/ mammalian target of rapamycin (mTOR) signaling pathway. All of these abnormalities were prevented or markedly diminished by partial or complete genetic removal of tau. We identify disinhibition of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a negative PI3K regulator that tau controls, as a plausible mechanism and demonstrate that tau interacts with PTEN via tau’s proline-rich domain. Our findings suggest an enabling role of tau in the pathogenesis of autism and identify tau reduction as a potential therapeutic strategy for some of the disorders that cause this condition.

Keywords

Akt
autism spectrum disorders
Cntnap2
megalencephaly
mTOR
PI3 kinase
PTEN
Scn1a
Shank3
tau

Cited by (0)

3

Lead Contact